Subsidiary of Alphabet
Isomorphic Labs Limited [1] is a London -based drug discovery company, which uses artificial intelligence for drug discovery .[2] [3] [4] Isomorphic Labs was founded by Demis Hassabis .[5] [3] The company was incorporated on February 4, 2021 and announced on November 5, 2021.[2] [6] It was established under Alphabet Inc. as a spin-off from its AI research lab DeepMind .[2] [3] [6] Hassabis is the CEO and founder.[3]
The company draws upon DeepMind's AlphaFold 2 technology, which can be used to predict protein structures in the human body with high accuracy, allowing its researchers to find new target pathways for drug delivery .[6] [7]
In December 2022, Isomorphic Labs announced its second office location in Lausanne, Switzerland .[6] [8]
In January 2024, Isomorphic Labs partnered with Novartis AG and Eli Lilly & Company to work together on AI drug discovery and research.[9]
^ "ISOMORPHIC LABS LIMITED overview - Find and update company information - GOV.UK" . Companies House . February 24, 2021. Retrieved August 20, 2023 .
^ a b c Shead, Sam (November 5, 2021). "Google-parent Alphabet has set up a new lab that will use A.I. to try to discover new drugs" . CNBC . Archived from the original on November 5, 2021. Retrieved November 9, 2021 .
^ a b c d Coldewey, Devin (November 4, 2021). "Isomorphic Labs is Alphabet's play in AI drug discovery" . TechCrunch . Retrieved August 23, 2022 .
^ Crist, Ry (November 4, 2021). "Alphabet launches Isomorphic Labs, an AI-driven drug discovery startup" . CNET .
^ Shead, Sam (November 5, 2021). "Google-parent Alphabet has set up a new lab that will use A.I. to try to discover new drugs" . CNBC . Retrieved November 30, 2023 .
^ a b c d Criddle, Cristina; Johnston, Ian (December 3, 2022). "DeepMind spin-off steps up effort to use AI to create new drugs" . Financial Times . Archived from the original on December 5, 2022. Retrieved April 28, 2023 .
^ Quach, Katyanna (November 8, 2021). "Alphabet launches new AI drug discovery startup, Isomorphic Labs, led by DeepMind CEO" . The Register . Archived from the original on November 27, 2022. Retrieved April 28, 2023 .
^ Aaron Hurst (December 5, 2022). "DeepMind spin-off Isomorphic Labs announces drug discovery scale plans" . Information Age .
^ Barton, Samantha (January 8, 2024). "Alphabet's Isomorphic Labs to collaborate with Novartis, Lilly on AI-driven drug discovery" . Fortune .